WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Disclosures for additional planners can be found here.

Faculty

George Kassianos, CBE, MD (Hons), FRCGP

General Practitioner
Royal College of General Practitioners Immunisation Lead
President, British Global and Travel Health Association
London, United Kingdom

Disclosures

George Kassianos, CBE, MD (Hons), FRCGP, has the following relevant financial relationships:
Consultant or advisor for: Merck Sharp & Dohme; Novavax; Pfizer; Sanofi; Seqirus; Takeda; Valneva

Paolo Bonanni, MD

Professor of Hygiene
School of Medicine
Director
Department of Health Sciences
University of Florence
Florence, Italy

Disclosures

Paolo Bonanni, MD, has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; GlaxoSmithKline; Janssen; Merck Sharp & Dohme; Moderna; Pfizer; Sanofi Pasteur; Seqirus
Speaker or member of speakers bureau for: AstraZeneca; GlaxoSmithKline; Janssen; Merck Sharp & Dohme; Moderna; Pfizer; Sanofi Pasteur; Seqirus
Research funding from: AstraZeneca; GlaxoSmithKline; Merck Sharp & Dohme; Pfizer; Sanofi Pasteur; Seqirus

Marta Boffito, MD, PhD, FRCP

Professor
Department of Infectious Diseases
Imperial College London
Consultant Physician
Chelsea and Westminster Hospital
London, United Kingdom

Disclosures

Marta Boffito, MD, PhD, FRCP, has the following relevant financial relationships:
Consultant or advisor for: Atea; Cipla; Gilead Sciences; GlaxoSmithKline; Merck Sharp & Dohme; Mylan; Pfizer; Roche; ViiV Healthcare
Speaker or member of speakers bureau for: Gilead Sciences; GlaxoSmithKline; Janssen; Merck Sharp & Dohme; Mylan; Pfizer; ViiV Healthcare
Research funding from: Gilead Sciences; GlaxoSmithKline; Merck Sharp & Dohme; Moderna; Novavax; Roche; Valneva; ViiV Healthcare

Editors

Shanthi Voorn, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Shanthi Voorn, PhD, has no relevant financial relationships.

Eloise Ballard, PhD

Scientific Content Manager, WebMD Global, LLC

Disclosures

Eloise Ballard, PhD, has no relevant financial relationships.

Compliance Reviewer

Yaisanet Oyola, MD

Associate Director, Accreditation and Compliance

Disclosures

Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

From Medscape Education

What COVID-19 Vaccines Can and Cannot Do: Setting Realistic Goals in the Current Pandemic

Authors: George Kassianos, CBE, MD (Hons), FRCGP; Paolo Bonanni, MD; Marta Boffito, MD, PhD, FRCPFaculty and Disclosures

processing....

Transcripción en español

Download the pdf.

Download Now

« Return to: What COVID-19 Vaccines Can and Cannot Do: Setting Realistic Goals in the Current Pandemic

Download Slides

Activity Transcript

PDF Downloads

Patient Handout

Transcript Downloads

Print
Like Tweet

Faculty and Disclosures

Faculty

George Kassianos, CBE, MD (Hons), FRCGP

Paolo Bonanni, MD

Marta Boffito, MD, PhD, FRCP